EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

3D genome organization shapes DNA damage susceptibility to platinum-based drugs

Ye Wang iD, Asli Yildirim, Lorenzo Boninsegna, Valentina Christian, Sung-Hae L Kang, Xianghong Jasmine Zhou, Frank Alber

Nucleic Acids Research · 2025

DOI: 10.1093/nar/gkaf315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, 2025. Verfasst von Ye Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Quantitative and Computational Biosciences (QCBio), University of California Los Angeles, Los Angeles CA90095, United States. Hauptthemen laut MEDLINE: DNA Damage, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIH HHS, NCI NIH HHS, NHGRI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Platinum (Pt) drugs are widely utilized in cancer chemotherapy. Although cytotoxic and resistance mechanisms of Pt drugs have been thoroughly explored, it remains elusive what factors affect the receptiveness of DNA to drug-induced damage in nuclei. Here, we demonstrate that nuclear locations of chromatin play a key role in Pt drug-induced DNA damage susceptibility in vivo. By integrating data from damage-seq experiments with 3D genome structure information, we show that nuclear locations of chromatin relative to specific nuclear bodies and compartments explain patterns of cisplatin DNA damage susceptibility. This aligns with observations of cisplatin enrichment in biomolecular condensates at certain nuclear bodies. Finally, 3D structure mapping of DNA damage reveals characteristic differences between nuclear distributions of oxaliplatin-induced DNA damage in drug resistant versus sensitive cells. DNA damage increases in gene-poor chromatin at the nuclear periphery, while it decreases in gene-rich regions located at nuclear speckles. This suggests a strategic redistribution of Pt drug-induced damage in nuclei during chemoresistance development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DNA DamageAntineoplastic AgentsHumansChromatinCisplatinCell NucleusOxaliplatinDrug Resistance, NeoplasmCell Line, TumorPlatinumGenome, Human

Substanzen

ChromatinCisplatinAntineoplastic AgentsOxaliplatinPlatinum

Autor:innen und Institutionen

  • Institute of Quantitative and Computational Biosciences (QCBio), University of California Los Angeles, Los Angeles CA90095, United States.
  • Department of Microbiology, Immunology, and Molecular Genetics, University of California Los Angeles, 520 Boyer Hall, Los Angeles CA90095, United States.
  • Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, 10833 Le Conte Ave, Los Angeles CA90095, United States.

ORCID-Profile: Ye Wang

Förderung

  • NIH HHS
  • NCI NIH HHS
  • NHGRI NIH HHS
  • National Institutes of Health

Zitieren

APA

Wang, Y., Yildirim, A., Boninsegna, L., Christian, V., Kang, S. L., Zhou, X. J., & Alber, F. (2025). 3D genome organization shapes DNA damage susceptibility to platinum-based drugs. Nucleic Acids Research. https://doi.org/10.1093/nar/gkaf315

Vancouver

Wang Y, Yildirim A, Boninsegna L, Christian V, Kang SL, Zhou XJ, et al. 3D genome organization shapes DNA damage susceptibility to platinum-based drugs. Nucleic Acids Research. 2025. doi:10.1093/nar/gkaf315

BibTeX
@article{Wang2025,
  author = {Wang, Ye and Yildirim, Asli and Boninsegna, Lorenzo and Christian, Valentina and Kang, Sung-Hae L and Zhou, Xianghong Jasmine and Alber, Frank},
  title = {3D genome organization shapes DNA damage susceptibility to platinum-based drugs},
  journal = {Nucleic Acids Research},
  year = {2025},
  doi = {10.1093/nar/gkaf315}
}
Kostenlos starten →